Gastrointestinal Infections

Top Story

Few patients starting biologics, DMARDs screened for HBV, HCV

Few patients starting biologics, DMARDs screened for HBV, HCV
November 13, 2019
In the Journals

EMR hard stop reduces repeat C. difficile testing

November 12, 2019
A hard stop clinical decision support tool embedded in the electronic medical record significantly reduced repeat Clostridioides difficile toxin enzyme immunoassay, or…
FDA NewsPerspective

FDA approves Talicia for H. pylori infection in adults

November 4, 2019
The FDA approved Talicia for the treatment of Helicobacter pylori infection in adults, manufacturer Redhill Biopharma announced. H. pylori infection is the major cause…
Meeting NewsPerspective

85% hepatitis B vaccine coverage for infants: ‘It takes a lot to get there’

October 31, 2019
NEW ORLEANS — Quality improvement projects focused on education and multidisciplinary cooperation have been successful at improving hepatitis B vaccination rates…
More Headlines »
CME

New Trends in Early Recognition of CDI and CMV in HSCT:
A Care Team Forum

This activity is supported by an educational grant from Merck & Co., Inc.

Hematopoietic stem cell transplantation (HSCT) has revolutionized the treatment of many blood disorders and has seen…
More »
Meeting News

Few patients starting biologics, DMARDs screened for HBV, HCV

November 13, 2019
ATLANTA — Less than a quarter of patients in a national rheumatology registry were screened for hepatitis B or C…
More »
Video
Meeting News

VIDEO: Increased surveillance fuels hepatitis elimination in Africa

April 29, 2019
More »